Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Beta Bionics Inc (BBNX)

Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 GlobeNewswire - Wed Apr 16, 3:05PM CDT

BBNX : 11.14 (+1.83%)
Beta Bionics to Host Investor Event on June 22, 2025 GlobeNewswire - Wed Apr 9, 6:30AM CDT

BBNX : 11.14 (+1.83%)
Beta Bionics Announces Board Appointment of Gerard Michel GlobeNewswire - Thu Mar 27, 3:45PM CDT

BBNX : 11.14 (+1.83%)
DCTH : 11.63 (+0.69%)
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 GlobeNewswire - Tue Mar 25, 3:02PM CDT

BBNX : 11.14 (+1.83%)
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 GlobeNewswire - Thu Feb 27, 6:00AM CST

BBNX : 11.14 (+1.83%)
Biotech research by Gorodenkoff via Shutterstock
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO? Barchart - Wed Feb 5, 12:32PM CST

This healthcare technology company is guiding for revenue growth of 150% for Q4.

BBNX : 11.14 (+1.83%)
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares GlobeNewswire - Fri Jan 31, 4:56PM CST

BBNX : 11.14 (+1.83%)
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering GlobeNewswire - Wed Jan 29, 9:34PM CST

BBNX : 11.14 (+1.83%)

Barchart Exclusives

1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ Barchart - 20 minutes ago
One Wall Street analyst is backing up Cathie Wood’s view that DraftKings is a stock to buy in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot